专利检索 ap:("Bausch Health Ireland Limited") AND inv:"Thejasvi Ramakrishna" 第 1 页

1.

发明申请
METHODS OF TREATING COVID-19 WITH RIFAXIMIN 有权

公开(公告)号：US20230116647A1

公开(公告)日：2023-04-13

申请号：US17913843

申请日：2021-03-24

申请人： Bausch Health Ireland Limited

发明人： Maxime Barakat , Howard Franklin , Zeev Heimanson , Thejasvi Ramakrishna , Jason Lamar Vittitow

IPC分类号： A61K31/437 , A61K45/06 , A61K31/4706

摘要： Provided herein are methods for treating COVID-19 or associated GI symptoms with rifaximin compositions.

2.

发明申请
SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY 有权

公开(公告)号：US20230111568A1

公开(公告)日：2023-04-13

申请号：US17913844

申请日：2021-03-24

申请人： Bausch Health Ireland Limited

发明人： Zeev Heimanson , Robert J. Israel , Thejasvi Ramakrishna , Jason Lamar Vittitow

IPC分类号： A61K31/437 , A61P1/16 , A61P25/28 , A61K31/7016 , A61K9/20 , A61K9/28

摘要： Provided herein are solid dispersions comprising rifaximin and methods of using the same for the treatment of Overt Hepatic Encephalopathy and complications associated with cirrhosis.